Elekta AB Debt to Equity Ratio 2013-2025 | EKTAY
Current and historical debt to equity ratio values for Elekta AB (EKTAY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Elekta AB debt/equity for the three months ending October 31, 2025 was 0.66.
| Elekta AB Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-10-31 | $2.09B | $0.90B | 2.33 |
| 2025-07-31 | $2.08B | $0.95B | 2.19 |
| 2025-04-30 | $1.91B | $0.84B | 2.28 |
| 2025-01-31 | $2.01B | $0.99B | 2.04 |
| 2024-10-31 | $2.13B | $1.01B | 2.11 |
| 2024-07-31 | $1.95B | $1.01B | 1.93 |
| 2024-04-30 | $1.94B | $1.01B | 1.91 |
| 2024-01-31 | $1.97B | $0.99B | 2.00 |
| 2023-10-31 | $1.93B | $0.94B | 2.05 |
| 2023-07-31 | $1.95B | $0.97B | 2.02 |
| 2023-04-30 | $1.90B | $0.93B | 2.04 |
| 2023-01-31 | $1.75B | $0.92B | 1.91 |
| 2022-10-31 | $1.68B | $0.85B | 1.98 |
| 2022-07-31 | $1.71B | $0.90B | 1.90 |
| 2022-04-30 | $1.96B | $1.00B | 1.95 |
| 2022-01-31 | $2.07B | $0.99B | 2.08 |
| 2021-10-31 | $0.78B | $0.22B | 3.54 |
| 2021-07-31 | $1.87B | $0.99B | 1.89 |
| 2021-04-30 | $1.90B | $0.94B | 2.03 |
| 2021-01-31 | $2.05B | $0.98B | 2.10 |
| 2020-10-31 | $1.99B | $0.91B | 2.19 |
| 2020-07-31 | $2.03B | $0.84B | 2.42 |
| 2020-04-30 | $2.11B | $0.84B | 2.50 |
| 2020-01-31 | $1.79B | $0.86B | 2.08 |
| 2019-10-31 | $1.79B | $0.81B | 2.20 |
| 2019-07-31 | $1.80B | $0.83B | 2.17 |
| 2019-04-30 | $1.80B | $0.86B | 2.09 |
| 2019-01-31 | $1.71B | $0.80B | 2.13 |
| 2018-10-31 | $1.74B | $0.77B | 2.25 |
| 2018-07-31 | $1.71B | $0.78B | 2.20 |
| 2018-04-30 | $1.75B | $0.96B | 1.82 |
| 2018-01-31 | $1.64B | $0.85B | 1.93 |
| 2017-10-31 | $1.66B | $0.83B | 1.99 |
| 2017-07-31 | $1.53B | $0.76B | 2.02 |
| 2017-04-30 | $1.62B | $0.78B | 2.09 |
| 2017-01-31 | $1.46B | $0.71B | 2.07 |
| 2016-10-31 | $1.57B | $0.77B | 2.05 |
| 2016-07-31 | $1.55B | $0.78B | 1.99 |
| 2016-04-30 | $1.55B | $0.76B | 2.03 |
| 2016-01-31 | $1.54B | $0.75B | 2.04 |
| 2015-10-31 | $1.56B | $0.79B | 1.98 |
| 2015-07-31 | $1.73B | $0.82B | 2.12 |
| 2015-04-30 | $1.96B | $0.90B | 2.19 |
| 2015-01-31 | $1.66B | $0.81B | 2.05 |
| 2014-10-31 | $1.64B | $0.83B | 1.99 |
| 2014-07-31 | $1.71B | $0.97B | 1.76 |
| 2014-04-30 | $1.78B | $0.96B | 1.86 |
| 2014-01-31 | $1.62B | $0.81B | 2.00 |
| 2013-10-31 | $1.60B | $0.78B | 2.05 |
| 2013-07-31 | $1.55B | $0.84B | 1.84 |
| 2013-04-30 | $1.61B | $0.84B | 1.93 |
| 2013-01-31 | $1.51B | $0.72B | 2.09 |
| 2012-10-31 | $1.50B | $0.71B | 2.12 |
| 2012-07-31 | $1.40B | $0.69B | 2.04 |
| 2012-04-30 | $1.55B | $0.76B | 2.04 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.377B | $1.708B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.511B | 27.63 |
| Intuitive Surgical (ISRG) | United States | $210.153B | 82.22 |
| IDEXX Laboratories (IDXX) | United States | $56.962B | 56.57 |
| Edwards Lifesciences (EW) | United States | $49.401B | 33.12 |
| IQVIA Holdings (IQV) | United States | $41.282B | 23.02 |
| Alcon (ALC) | Switzerland | $39.524B | 26.71 |
| Mettler-Toledo (MTD) | United States | $30.339B | 35.49 |
| DexCom (DXCM) | United States | $26.287B | 36.24 |
| STERIS (STE) | Ireland | $25.206B | 26.02 |
| Waters (WAT) | United States | $23.626B | 31.24 |
| Coloplast (CLPBY) | Denmark | $19.855B | 33.88 |
| Hologic (HOLX) | United States | $16.689B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.750B | 0.00 |
| Globus Medical (GMED) | United States | $12.644B | 26.54 |
| Penumbra (PEN) | United States | $12.627B | 88.83 |
| Masimo (MASI) | United States | $7.462B | 23.91 |
| Glaukos (GKOS) | United States | $6.486B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.358B | 20.20 |
| Teleflex (TFX) | United States | $4.986B | 7.94 |
| TransMedics (TMDX) | United States | $4.684B | 55.49 |
| LivaNova (LIVN) | United Kingdom | $3.517B | 19.00 |
| Alphatec Holdings (ATEC) | United States | $3.365B | 0.00 |
| Veracyte (VCYT) | United States | $3.323B | 37.87 |
| Integer Holdings (ITGR) | United States | $2.954B | 13.87 |
| Artivion (AORT) | United States | $2.101B | 96.41 |
| UFP Technologies (UFPT) | United States | $1.986B | 26.22 |
| Nihon Kohden (NHNKY) | Japan | $1.934B | 16.88 |
| PROCEPT BioRobotics (PRCT) | United States | $1.834B | 0.00 |
| AxoGen (AXGN) | United States | $1.546B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.471B | 0.00 |
| IRadimed (IRMD) | United States | $1.259B | 59.97 |
| Integra LifeSciences Holdings (IART) | United States | $1.058B | 5.73 |
| OPKO Health (OPK) | United States | $1.044B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.982B | 0.00 |
| SiBone (SIBN) | United States | $0.887B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.887B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.675B | 39.27 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.625B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.588B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.586B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.44 |
| NeuroPace (NPCE) | United States | $0.557B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.459B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.448B | 12.38 |
| ClearPoint Neuro (CLPT) | United States | $0.424B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.380B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.365B | 60.82 |
| RxSight (RXST) | United States | $0.363B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.296B | 2.21 |
| CVRx (CVRX) | United States | $0.213B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.185B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.162B | 0.00 |
| Neuronetics (STIM) | United States | $0.142B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.141B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.138B | 0.00 |
| Solana (HSDT) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.098B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.083B | 0.00 |
| DarioHealth (DRIO) | United States | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.09 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |